LOS ANGELES--(BUSINESS WIRE)--April 19, 2006--Abraxis BioScience, Inc. (NASDAQ:ABBI - News), an integrated, global biopharmaceutical company formed as a result of the merger between American BioScience, Inc. and American Pharmaceutical Partners, Inc., today announced it will release its 2006 first quarter financial results before the market opens on Friday, April 28, 2006. The company also said that senior management will host an investor conference call that same day at 11:30 a.m. EDT to review the company’s financial results and operations.
